Catalyst Wire Dossier Catalyst Wire Dossier

Living cellular skin substitute

· Acera Surgical, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Living cellular skin substitute, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU) [NA]

See pricing